| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 653864 | Null | 0.048939380959983 | -0.077205419 |
| NSC 658103 | Null | 0.048939380959983 | 0.18947835 |
| NSC 659949 | 14-Bromo-7-O-(2,3,6-trideoxy-2-fluoro-.alpha.-L-talo-hexo- pyranosyl)-4-demethoxydaunomycinone | 0.048939380959983 | 0.26794767 |
| NSC 662191 | Null | 0.048939380959983 | 0.18535495 |
| NSC 671392 | Null | 0.048939380959983 | 0.37273467 |
| NSC 673420 | Null | 0.048939380959983 | 0.60824703 |
| NSC 675000 | Null | 0.048939380959983 | 0.57415785 |
| NSC 676779 | Olean-12-en-28-oic acid, 3-.beta.-[3-O-(.beta.-L-arabinopyranosyl)- 6-methyl-.beta.-D-glucopyranuronosyloxy]-, [2-O-[[4-O-[3-O-(.beta.-L-arabinopyranosyl)- .beta.-D-xylopyranosyl]-3-O-(.beta.-D-xylop | 0.048939380959983 | 0.079844644 |
| NSC 677598 | Glutamamide, N-acetyl-1-O-(phenylmethyl)-.alpha.-normuramyl-prolyl- N(5)-[5-[(1-nitro-9-acridinyl)amino]pentyl]-, stereoisomer | 0.048939380959983 | 0.16982777 |
| NSC 681239 | Bortezomib | 0.048939380959983 | 0.15438325 |